Skip to main content
Go to Parent Project Muscular Dystrophy's website
Fundraiser Login
Open Mobile Menu
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
Close Menu
Blog
Sarepta Therapeutics Announces Update on ELEVIDYS Label, Company Restructuring
...
Post AAV Gene Therapy Resources
...
Capricor Therapeutics Receives Complete Response Letter Regarding Deramiocel (CAP-1002)
...
Connecting with Experts via PPMD For You
...
Medicaid, Reconciliation Passage, and What Comes Next for Our Community
...
Webinar Recording: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne
...
Arizona Becomes the Latest State to Require Newborn Screening for Duchenne
...
Edgewise Therapeutics Shares Positive Results on Sevasemten Program for Becker and Duchenne
...
Capricor Shares Regulatory Update on Deramiocel BLA for Duchenne
...
A Safety Update on ELEVIDYS – June 2025
...
1
2
3
…
117
>
